Document is current
Any future updates will be listed below
-
Authors
Qian, Juying
Yang, Hongbo
Huang, Jia
Chang, Shufu
Burton, Timothy
Gillins, Horace R.
Fathieh, Farhad
Nemati, Navid
Ramchandani, Shyam
Shadforth, Ian P.
Bridges, Charles R.
Ge, Junbo
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04034537 at ClinicalTrials.govDocuments that mention this clinical trial
Efficacy of a US-developed machine-learned coronary artery disease algorithm in China
https://doi.org/10.1007/s44337-025-00255-3
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 3 March 2025
First Online: 17 March 2025
Declarations
:
: CADChina (NCT04034537, published on clinicaltrials.gov), was approved by the Ethics Committee of Zhongshan Affiliated with Fudan University (August 7th, 2019) and Ministry of Science and Technology of the People's Republic of China (July 1st, 2020). Informed consent was obtained from all subjects. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: T.B., F.F., N.N. and S.R. are employees of Analytics for Life. H.R.G, I.P.S., and C.R.B. are employees of CorVista Health. J.G. is a member of the CorVista Health Medical Advisory Board.
